Seoul, South Korea

Woo Kyun Syn

This inventor holds 1 USPTO granted patent. Top assignee: Gs Caltex Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Woo Kyun Syn. Retrieved from https://idiyas.com/inventor/woo-kyun-syn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Woo Kyun Syn and His Patent on 2,3-Butanediol

Introduction

Woo Kyun Syn is an inventor based in Seoul, South Korea, associated with Gs Caltex Corporation. His patent work concerns the potential use of 2,3-butanediol in pharmaceutical and cosmetic compositions.

Latest Patents

Syn is associated with 1 patent, titled “Composition Containing 2,3-Butanediol as Active Ingredient.” The patent describes compositions containing 2,3-butanediol for potential use in treating inflammatory and skin conditions, including wrinkles. It identifies the compound as a possible active ingredient in pharmaceutical or cosmetic products, with anti-inflammatory, antioxidant, and anti-wrinkle applications.

Career Highlights

Syn’s listed invention focuses on applying a chemical compound to health and skincare products. The patent describes administering or applying a composition to a subject in need, while identifying potential uses rather than establishing clinical effectiveness.

Collaborations

Syn’s listed coworkers include Hyo Hak Song and Jong Myoung Park. His company affiliation is Gs Caltex Corporation.

Conclusion

Woo Kyun Syn’s patent highlights research into the potential pharmaceutical and cosmetic applications of 2,3-butanediol.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…